<DOC>
	<DOCNO>NCT02355145</DOCNO>
	<brief_summary>A non-interventional , multicentre study observe main criterion use clinical practice physician select second-line add-on therapy patient inadequately metformin-controlled type 2 diabetes 2 time point 1 year distance . Data collect review medical record patient type 2 diabetes add-on therapy time present endocrinologist accord clinical practice . The patient participate one study visit , time enrolment . Two study group define two time-points .</brief_summary>
	<brief_title>Non-inteRvEntional Study Observe rAtionaLe Select add-on TherapY Type 2 Diabetes Inadequately Controlled With Metformin .</brief_title>
	<detailed_description>A non-interventional , multicenter study observe main criterion use clinical practice physician select second-line add-on therapy patient inadequately metformin-controlled type 2 diabetes 2 time point 1 year distance . The study enrol minimum 500 patient time point , result total least 1000 approximately 50 investigator Bulgaria . Each investigator recruit approximately 10 subject . The assignment patient particular add-on therapy decide advance NIS protocol , fall within current practice prescription medicine clearly separate decision include subject study . No additional diagnostic monitoring procedure shall apply patient , daily clinical practice epidemiological method shall use analysis collect data . The intention study collect data patient type 2 diabetes add-on therapy routine clinical care . The patient participate one study visit , time enrolment , provide write informed consent , thus allow access data . Data collect review medical record patient . Two study group define time-point - one study group enrol moment 1 evaluation ( Feb - Mar 2015 ) one study group enrol moment 2 evaluation ( Feb - Mar 2016 ) . A patient enrol study moment 1 may enrol study moment 2 . No patient prospectively followed-up study . Investigators participate non-interventional study diabetologists outpatient setting , group specialist treat T2DM patient Bulgaria .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Provision subject inform consent Female and/or male age 18 year Diagnosis type 2 diabetes mellitus Patients consider inadequately control metformin current treatment base addon diabetes therapy Diagnosis type 1 diabetes Current antidiabetes treatment oral monotherapy Insulin treatment type 2 diabetes Current participation clinical trial Patient enrol study point 1 enrol point 2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>type 2 diabetes , add-on diabetes therapy , rationale</keyword>
</DOC>